BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26193870)

  • 1. Proangiogenic factors in the development of HCC in alcoholic cirrhosis.
    Machado MV; Cortez-Pinto H
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S104-8. PubMed ID: 26193870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
    Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
    Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
    Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
    Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in alcoholic liver disease.
    Szabo G; Satishchandran A
    Semin Liver Dis; 2015 Feb; 35(1):36-42. PubMed ID: 25632933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
    Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
    Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.
    Sutton A; Nahon P; Pessayre D; Rufat P; Poiré A; Ziol M; Vidaud D; Barget N; Ganne-Carrié N; Charnaux N; Trinchet JC; Gattegno L; Beaugrand M
    Cancer Res; 2006 Mar; 66(5):2844-52. PubMed ID: 16510607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.
    Trepo E; Guyot E; Ganne-Carrie N; Degre D; Gustot T; Franchimont D; Sutton A; Nahon P; Moreno C
    Hepatology; 2012 Apr; 55(4):1307-8. PubMed ID: 22162034
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma.
    Felgendreff P; Raschzok N; Kunze K; Leder A; Lippert S; Klunk S; Tautenhahn HM; Hau HM; Schmuck RB; Reutzel-Selke A; Sauer IM; Bartels M; Morgül MH
    Biomarkers; 2020 Feb; 25(1):62-68. PubMed ID: 31701763
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetics of Alcoholic Liver Disease.
    Anstee QM; Daly AK; Day CP
    Semin Liver Dis; 2015 Nov; 35(4):361-74. PubMed ID: 26676812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma associated with alcoholic liver disease: a clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2.
    Ohhira M; Fujimoto Y; Matsumoto A; Ohtake T; Ono M; Kohgo Y
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):378A-382A. PubMed ID: 8986242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evaluation of apoptotic versus antiapoptotic angiogenic markers in hepatocellular carcinoma.
    Abdel Aziz MT; El-Miligy D; Amin MA; El Ansari A; Ahmed HH; Marzouk S; Sabry D
    Clin Biochem; 2008 Aug; 41(12):1008-14. PubMed ID: 18339319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
    Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythrocytosis in patients with hepatocarcinoma in alcoholic cirrhosis: ectopic production of erythropoietin?].
    Giovanardi P; Sacchetti C; Cameroni P; Grandi M
    Recenti Prog Med; 1998 May; 89(5):250-2. PubMed ID: 9676132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.